Searched for
INNOVATIVE GENE THERAPY
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Karnataka approves initiatives worth over Rs 27 crore for startups, biotechKarnataka's IT/BT department has approved four initiatives totaling over Rs 27 crore to boost innovation across the state. These projects i...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Scientists say this simple thing may reverse brain aging and restore memory in weeksScientists have developed an experimental nasal spray that shows promise in reversing brain aging. This treatment targets chronic inflammat...
- India should chart own path in treatment of rare diseases: ICMR chiefIndia is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity ...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- A cure for type-1 diabetes is within reach: Breakthrough stem cell therapies show promise in 2025Hope is on the horizon for Type-1 diabetes patients. New stem cell therapies are showing remarkable progress. These treatments aim to repla...
- For the first time, Huntington’s disease slowed: what scientists achieved and how gene therapy blocks toxic brain proteinHuntington's disease has been successfully treated for the first time with an experimental gene therapy called AMT-130, which uses a clever...
- From pharmacy to innovation hub: Why India needs a regulatory revolution in biotechIndia aims to transition from a global pharmacy to an innovation hub by reforming its regulatory landscape. The focus is on AI-powered appr...
- Indian biotech firm develops world’s first, indigenous Bi-Specific 3rd generation CAR T cells for cancer treatmentThis therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly r...
- Eco Survey administers a big dose of reality to Indian pharmaThe Economic Survey 2024-25 emphasises the need for increased innovation, new drug development, and biopharmaceutical advancements in India...
- Driving innovation: India's foray into gene and cell therapiesIndia is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.
- East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro LabsEast Ocyon Bio aims to reshape India’s role in the global biotech landscape, creating an ecosystem where pioneering therapies are developed...
- Affordable gene and cell therapies need of the hour: Dr Kapil Bharti, Scientific Director, National Eye InstituteLimitless potential for future global advancements in gene therapies is originating from India, said Dr David Gamm.
- Indian Pharma Congress: Gene-cell therapy, preventive medicine future of health care, says expert"The focus will be on prevention rather than cure. In this, citizens are diagnosed technically to see what diseases they could be afflicted...
- Immuneel Therapeutics raises $15 million in fundingImmuneel Therapeutics is working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular im...
- ET Q&A: Need Government investments to develop cure for epidemics like Covid-19In the absence of sustained investments by government, the cure for epidemics such as Covid-19 becomes a challenge, Novartis global CEO Vas...
- Biotech startups choosy on deals with big pharma: Bayer executiveRegulatory and clinical development expertise and the might to take products through the commercialization stages offer a natural edge to b...
- ‘Innovation can only be funded by branded therapies’In an e-mail interview with ET, Henri A Termeer, Chairman, President & CEO of Genzyme Corporation discusses the latest trends in the area o...
Load More
